HIV-1LAI Nef blocks the development of hematopoietic stem/progenitor cells into T lymphoid cells

Our results demonstrate that Nef compromises the development of HSPCs into T lymphoid cells, especially CD4+ T cells. This observation suggests that therapeutics targeting Nef may correct HIV-1-associated hematopoietic abnormalities, especially defects in T-cell development.